Home > Insider Trading > Filing (0001104659-20-076542)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1001316	Tg Therapeutics Inc.	TGTX	Pharmaceutical Preparations (2834)	363898269

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1448888	James William Kennedy	2 Gansevoort Street, 9Th Floor New York NY 10014		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-06-17	7,745	$18.27	94,633	No	4	S	Direct
Common Stock	Disposition	2020-06-22	15,000	$0.00	109,633	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	A	Direct

Footnotes

In connection with the vesting of 15,000 shares on June 16, 2020, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Kennedy's tax obligations. Mr. Kennedy had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
Represents the weighted average sales price. The range of prices for such transaction was $18.20 to $18.36. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Includes shares of restricted Common Stock, which vest over various time periods.
Reflects a grant of restricted shares that will vest on June 22, 2023.